Qualifying training in EXistential psychodynamic therapy

Applications now open for Autumn 2027

Applications are now open for ECPT’s qualifying training in Existential Psychodynamic Therapy, delivered in partnership with Glasgow Caledonian University (GCU) as a pathway on its PgDip / MSc Counselling Practice.

This part-time training combines psychodynamic and existential approaches to counselling and psychotherapy, bringing together theoretical study, experiential learning and clinical practice. Students undertake supervised clinical practice through ECPT’s own therapy service, developing their therapeutic skills within a supportive training environment.

The PgDip takes two years to complete, with the option to undertake an additional dissertation year through GCU’s MSc Counselling Practice.

Why choose this programme?

✔ An integrated approach to existential and psychodynamic therapy

✔ Built-in clinical placement at ECPT’s own therapy service

✔ Training designed to support eligibility for professional accreditation with NCPS, BACP or COSCA, subject to the relevant body's requirements

✔ Eligible students can apply for £7,000 in SAAS funding towards tuition fees

✔ The option to progress from the PgDip to the MSc through an additional dissertation module at GCU

✔ Small cohorts, with a maximum of 25 students, and a high tutor-to-student ratio

Core entry requirements

• COSCA Certificate in Counselling Skills or equivalent

• A degree in any subject

• Proof of English language proficiency, unless English is your first language or you hold a UK degree

• Home fee status, in line with GCU's eligibility requirements

Interested in applying?

Applications are now open for the September 2027 cohort. Complete the form below to access the course brochure and further information about the programme. You will find the link to the application form in the final page of the digital brochure.

For further information, please email info@ecpt.org.uk.

Apply by 9am 14th December 2026 to be considered for our early-entry interviews in January 2027.